The direct involvement of Brachyury in CHGA, SYP, AR, Bcl2, ERG and PTEN expression is still unclear; however, the association with these well-established markers of PCa progression supports the importance of Brachyury as a new biomarker of PCa aggressiveness. The gene discussed is BCL2; the disease is posterior cortical atrophy.